HEMANGEOL
Total Payments
$167,044
Transactions
672
Doctors
390
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $53,230 | 159 | 80 |
| 2023 | $58,580 | 197 | 132 |
| 2022 | $22,526 | 114 | 97 |
| 2021 | $26,243 | 136 | 112 |
| 2020 | $6,466 | 66 | 49 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Travel and Lodging | $83,188 | 54 | 49.8% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $27,377 | 15 | 16.4% |
| Honoraria | $23,700 | 13 | 14.2% |
| Food and Beverage | $23,030 | 588 | 13.8% |
| Grant | $5,000 | 1 | 3.0% |
| Consulting Fee | $4,750 | 1 | 2.8% |
Top Doctors Receiving Payments for HEMANGEOL — Page 16
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , NP | Dermatology | New York, NY | $13.55 | 1 |
| , M.D | Student in an Organized Health Care Education/Training Program | La Mesa, CA | $13.51 | 1 |
| , ARNP | Family | Oviedo, FL | $12.79 | 1 |
| , MD | Dermatology | New York, NY | $12.62 | 1 |
| , M.D | Psychiatry | South Miami, FL | $11.66 | 1 |
| , MD | Radiation Oncology | Atlanta, GA | $11.12 | 1 |
| , MD | Dermatology | Gastonia, NC | $11.12 | 1 |
| , MD | Dermatology | Gastonia, NC | $11.12 | 1 |
| , M.D | MOHS-Micrographic Surgery | Miami, FL | $10.56 | 1 |
| Anand Haryani | MOHS-Micrographic Surgery | Sebastian, FL | $10.00 | 1 |
| , MD | Dermatology | Sebastian, FL | $10.00 | 1 |
| , M.D | Pediatric Dermatology | Hampton, VA | $9.92 | 2 |
| , MD | Pediatric Cardiology | Tucson, AZ | $9.66 | 1 |
| , M.D | Dermatology | Miami Beach, FL | $9.42 | 1 |
| , MD | Dermatology | Pembroke Pines, FL | $8.89 | 1 |
| , M.D | Specialist | Palm Beach Gardens, FL | $4.72 | 1 |
Ad
Manufacturing Companies
- Pierre Fabre Pharmaceuticals, Inc. $167,044
Product Information
- Type Drug
- Total Payments $167,044
- Total Doctors 390
- Transactions 672
About HEMANGEOL
HEMANGEOL is a drug associated with $167,044 in payments to 390 healthcare providers, recorded across 672 transactions in the CMS Open Payments database. The primary manufacturer is Pierre Fabre Pharmaceuticals, Inc..
Payment data is available from 2020 to 2024. In 2024, $53,230 was paid across 159 transactions to 80 doctors.
The most common payment nature for HEMANGEOL is "Travel and Lodging" ($83,188, 49.8% of total).